Success Metrics

Clinical Success Rate

33.3%

Based on 1 completed trials

Completion Rate

33%(1/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

2(50%)

Phase Distribution

Ph phase_3

25%

Ph not_applicable

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 3Large-scale testing

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

25.0%

1 of 4 finished

Non-Completion Rate

75.0%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(1)

Terminated(3)

Detailed Status

Terminated2

Withdrawn1

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

33.3%

Most Advanced

Phase 3

Trials by Phase

Phase 31 (25.0%)

N/A3 (75.0%)

Trials by Status

withdrawn125%

completed125%

terminated250%

Recent Activity

0 active trials

Showing 4 of 4

terminatednot_applicable

Optimal Management of Malignant Dysphagia

NCT01366833

terminatedphase_3

Palliation Dysphagia Cancer Oesophagus Stent+Brachytherapy Versus Brachytherapy Only

NCT00653107

completednot_applicable

Study Evaluating the Helical Ureteral Stent

NCT01739725

withdrawnnot_applicable

Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent

NCT01875549

Clinical Trials (4)

Showing 4 of 4 trials

NCT01366833Not Applicable

Optimal Management of Malignant Dysphagia

Terminated

NCT00653107Phase 3

Palliation Dysphagia Cancer Oesophagus Stent+Brachytherapy Versus Brachytherapy Only

Terminated

NCT01739725Not Applicable

Study Evaluating the Helical Ureteral Stent

Completed

NCT01875549Not Applicable

Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 4